OS Therapies Statistics
Total Valuation
OS Therapies has a market cap or net worth of $42.99 million. The enterprise value is $40.02 million.
Important Dates
The last earnings date was Friday, May 16, 2025, before market open.
Earnings Date | May 16, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OS Therapies has 28.10 million shares outstanding. The number of shares has increased by 270.21% in one year.
Current Share Class | 28.10M |
Shares Outstanding | 28.10M |
Shares Change (YoY) | +270.21% |
Shares Change (QoQ) | -2.34% |
Owned by Insiders (%) | 23.21% |
Owned by Institutions (%) | 1.39% |
Float | 18.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 70.05 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16
Current Ratio | 1.16 |
Quick Ratio | 0.84 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -9.14 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -263.81% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -1,566.99% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.65M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Dividends & Yields
OS Therapies does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -270.21% |
Shareholder Yield | -270.21% |
Earnings Yield | -30.87% |
FCF Yield | -23.45% |
Analyst Forecast
The average price target for OS Therapies is $18.00, which is 1,076.47% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.00 |
Price Target Difference | 1,076.47% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |